Background: Traditionally, skull base tumors with intraventricular extension are approached via
open craniotomy or transventricular approaches. However, craniopharyngiomas are increasingly
resected via an endoscopic endonasal approach (EEA); yet those with intraventricular
extension are of increased complexity and EEA with this degree of extension is not
well studied.
Methods: Patients undergoing EEA for resection of craniopharyngioma with third ventricular
involvement between 2002 and 2015 were retrospectively reviewed. Tumor characteristics
and outcomes were reviewed and compared with previously published EEA and transcranial
approach (TCA) studies for all craniopharyngioma locations. Comparison of these groups
was done via meta-analysis and a random effects model.
Results: Sixty-two patients were included. Average tumor volume was 13.93 cm3 with an average 2.61 cm3 (17.3%) intraventricular volume. Patients presented with visual impairment (75.8%),
panhypopituitarism (29.0%), headache (16.1%), and diabetes insipidus (16.1%). Gross
total resection (GTR) was achieved in 47% of all cases (56% of cases where GTR was
the goal); after 2012 the overall GTR rate increased to 77%. Of those presenting with
visual impairment, 97.9% experienced improvement or stability of vision. The rates
of postoperative cerebrospinal fluid (CSF) leak and meningitis was 19 and 8.1%, respectively.
When nasoseptal flap reconstruction (since 2006) was used, the CSF leak rate dropped
to 10%. Two patients had tumor bed/intraventricular hemorrhage requiring reoperation
and one patient had an epidural hematoma requiring evacuation. There were no postoperative
mortalities. Six (9.6%) patients required shunting prior to tumor resection. Overall,
25% underwent postoperative shunt placement with 7 out of 10 patients (70%) treated
prior to introduction and routine use of the nasoseptal flap and only 7 of 46 (15%)
required a shunt following routine use of nasoseptal flap reconstruction. Meta-analysis
demonstrated overall similarity in presenting features and outcomes between the present
cohort for intraventricular lesions, EEA, and TCA for all craniopharyngiomas. TCA
demonstrated a higher GTR rate, however, with heterogeneity in the model (sizable
study variation). EEA for craniopharyngioma with intraventricular extension showed
improved visual outcomes compared with TCA but also increased incidence of CSF leaks
without concomitant increase in rates of meningitis (again with heterogeneity in the
random effects model).
Conclusion: EEA for craniopharyngiomas with intraventricular extension shows similar outcomes
to those of TCA and EEA for all craniopharyngiomas and expands one of the potential
anatomic limits of this approach. Given involvement of the ventricle, CSF leak/shunt
rates are expectedly high. GTR rates increased and CSF leak/shunt rates decreased
dramatically with time and the introduction of the nasoseptal flap. These outcomes
reflect the importance of an experienced team and demonstrate a clear learning curve.